Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon--α
The Korean Journal of Hematology · 2005
DOI: 10.5045/kjh.2005.40.2.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Korean Journal of Hematology, 2005. Verfasst von Yeon Seong Kim und 8 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Bone marrow fibrosis is associated with a poor prognosis in those patients with chronic myelogenous leukemia (CML). It is present at the initial diagnosis as well as during CML transformation. Although the effect of interferon-α therapy on marrow fibrosis has been controversial, imatinib mesylate has shown significant activity to reduce the CML-associated bone marrow fibrosis as well as the Philadelphia chromosome-positive cells. We report here on a case of the reversal of marrow fibrosis after imatinib mesylate therapy in a 67 year-old female patient suffering with CML that was refractory to interferon-α.
Zitieren
APA
Kim, Y. S., Kim, T. H., Kim, W. C., Jeon, Y. J., Kil, U. H., Lee, H. K., Kim, Y. S., Rho, S. Y., & Cho, S. G. (2005). Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon--α. The Korean Journal of Hematology. https://doi.org/10.5045/kjh.2005.40.2.124
Vancouver
Kim YS, Kim TH, Kim WC, Jeon YJ, Kil UH, Lee HK, et al. Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon--α. The Korean Journal of Hematology. 2005. doi:10.5045/kjh.2005.40.2.124
BibTeX
@article{Kim2005,
author = {Kim, Yeon Seong and Kim, Tae Hun and Kim, Won Chul and Jeon, Youn Joo and Kil, Uk Hyun and Lee, Hae Kyung and Kim, Yeong Sik and Rho, Sang Young and Cho, Seok Goo},
title = {Reversal of Marrow Fibrosis Following Imatinib Mesylate Therapy in a Patient with Chronic Myelogenous Leukemia Who Was Refractory to Interferon--α},
journal = {The Korean Journal of Hematology},
year = {2005},
doi = {10.5045/kjh.2005.40.2.124}
}
EUVIMED